VACCINATION RATES
Only 17% of targets to improve life around the world are likely to be reached by 2030, UN reports
Despite incremental progress in some areas, global sustainable development remains hindered by slow advancement and persistent challenges. Efforts in expanding technology access and renewable energy capacity show promise, but significant work is needed to address issues like gender equality and education to achieve the 2030 goals.
Is the US facing a surge in COVID-19 cases? Symptoms, variants, vaccines and other details
The US is facing a summer surge in COVID-19 cases. The new variants are spreading and this has yet again raised the importance of taking precautions.
This new genetic trait can be the key Alzheimer's cure? Here's what we know
Alzheimer's is a very common disease that plagues thousands of Americans in their prime. However, researchers have now stumbled upon a very new kind of genetic trait that can delay the effects of Alzheimer's, according to recent reports. An extended family based in Colombia's Medellin, was analyzed upon, to derive these results.
Bharat Bio's Rotavirus vaccine Rotavac may be unsafe for children: Study
A study found that Bharat Biotech's Rotavac vaccine used in the government's immunization program increases the risk of intussusception in infants, a condition where the intestine telescopes into itself, leading to potential serious consequences.
SII, the world’s largest vaccine maker, sees demand doubling in five years
Serum Institute of India Pvt. is gearing up to meet the growing demand for life-saving vaccines, with expectations to double sales in the next five years. The world's largest vaccine maker, based in Pune, currently has the capacity to produce 3 billion doses annually but only sells about half of that. CEO Adar Poonawalla is optimistic about the increasing uptake of vaccines globally as countries boost their healthcare budgets.
Own midcaps? Do a check & balance exercise to avoid decision of haste: 7 midcaps from different sectors with an upside potential of upto 49%
Every now and then the market goes through phases, where it prefers a certain set of stocks, not based on sector but based on the overall market cap. So, sometimes it is large caps, at other mid-caps. Now this partially happens, due to the flows which are coming to markets. For example, if more flows are coming to mid-cap or multicap schemes there is bound to be out performance in the mid-cap space. Now what it does is that it tends to create a sudden surge in mid-cap. Similarly when there is an outflow like the kind of one which we saw in March this year, midcap stocks tend to decline sharply. Essentially, it is the flows which impact the broader matrix of how midcaps behave. So there are phases not owning a midcap stocks appeared to sin and then there phase, where owning them appears to be sin. But if one focuses on the underlying business and some critical parameters, there is a possibility of getting rid of these phases of anxiety which keep coming to the street and create long term wealth.
- Go To Page 1
Are Covid vaccines related to unprecedented deaths in USA? Here's what research paper claims
Covid vaccines have come under the scrutiny across the world. Now a new research report has made shocking claims.
‘Doctors knew Covid vaccine’s side-effects killed my daughter. But they didn’t tell us’
Dr Snehal Lunawat was the first case in which the AEFI committee accepted there was a direct correlation between vaccination and death. Many of the petitioners, like her father Dilip, have questioned why information about the side-effects wasn’t made public earlier.
Union health secy highlights India's health achievements, future goals at WHO assembly
India, in collaboration with the World Health Organization (WHO), plans to strengthen its drug regulatory system to ensure quick access to high-quality medical products for all. Union Health Secretary Apurva Chandra highlighted the country's core capacity score of 86% to detect, assess, report, and respond to health emergencies, surpassing the Southeast Asia Region and Global average.
FLiRT variants of COVID-19 'dominate' globally, sparking worries over immune evasion
WHAT IS FLIRT COVID? The FLiRT variants, marked by mutations in the virus' spike protein, including KP.2 now prevalent in the US, have raised questions about immune response and vaccine efficacy. Despite a decline in hospitalizations, experts await updated vaccines targeting these variants amid ongoing surveillance and discussions among regulators.
HPV vaccines may protect men as well as women from cancer claims new study
Vaccinated women had a lower risk of developing cervical cancer within at least five years of getting the shots. For men, there were benefits too. Vaccinated men had a lower risk of developing any HPV-related cancer, such as cancers of the anus, penis and mouth and throat.
ICMR distances itself from BHU's Covaxin study, asks to explain why it should not seek Iegal and administrative action
The Indian Council of Medical Research (ICMR) has criticised Banaras Hindu University (BHU) researchers for incorrectly associating them with an observational study on the side effects of Bharat Biotech's Covid-19 vaccine, Covaxin. The study, which covered a one-year period after the vaccine was administered, found that nearly a third of the 926 participants reported adverse events of special interest (AESI).
Nearly 100 cases of Covid's new FLiRT variant KP.2 found in Maharashtra: Here are the most affected cities
Maharashtra identifies 91 cases of the Omicron subvariant KP.2, surpassing the JN.1 variant. Pune records the highest number at 51. Dr. Rajesh Karyakarte notes an increase in cases without a rise in hospitalizations. Other cases reported in various cities. FLiRT variants consist of KP.1.1 and KP.2 strains. Japanese researchers identify unique substitutions in the S protein of KP.2 variant.
Wall Street closes up, another weekly gain ahead of inflation data
Atlanta Fed President Raphael Bostic acknowledged recent clues the economy is slowing, but added the timing of rate cuts remains uncertain.
US stocks gain ahead of Fed officials' remarks; Dow nears 40,000 mark
Indexes were inching closer to record highs following a selloff last month, as a slew of economic data pointed to a cooling US labour market, raising expectations that the Fed will cut borrowing costs more than once this year. A much better-than-expected earnings season has also helped put the benchmark S&P 500 and the tech-heavy Nasdaq Composite on track for their third consecutive week of gains.
Good shot, bad shot: What you need to know about Covishield issue
Covishield Side Effects: Controversies surrounding vaccine side-effects persist despite Covid-19 waning. Covishield, developed by AstraZeneca and Oxford University, faces scrutiny in India following reports of rare side effects. Legal battles and demands for compensation have emerged as families of alleged victims seek justice. Experts stress the importance of understanding risks versus benefits in vaccine administration.
Nearly 12 pc of India's eligible children received no dose of measles vaccine, study finds
Researchers from the Ministry of Health and Family Welfare and Banaras Hindu University in Varanasi investigated previously overlooked critical aspects of measles vaccination, focusing on zero-doses, partially vaccinated, and those fully immunised. They analysed data of over 43,000 children aged 2-3 years, collected through the National Family Health Survey 2019-21 (NFHS-5).
Serum Institute says it already disclosed 'all side effects' of Covishield, clarifies it stopped making the vaccine in 2021
The Serum Institute of India has stopped manufacturing and providing additional doses of the Covishield vaccine due to concerns about its side effects. AstraZeneca has also withdrawn its Vaxzervria vaccine and marketing authorizations within Europe. The UK-based pharmaceutical company collaborated with the Serum Institute of India to provide the vaccine to the Indian government. Families of individuals who experienced adverse effects are pursuing legal action against AstraZeneca and the Serum Institute of India.
Disclosed all information on Covishield’s side effects in 2021, says SII
The Serum Institute of India (SII) has stated that the safety of vaccines remains "paramount" and that all information about the side effects of its Covishield vaccine against Covid-19 was disclosed in its packaging insert in 2021. The statement comes after a group of parents whose children died during the pandemic filed a case against the company. SII manufactured and supplied the vaccine under license from AstraZeneca, which admitted in court that the vaccine could cause a rare side effect.
Covishield deaths could be more than estimates: Parents
SII discloses TTS side-effects. Venugopalan Govindan raises Covishield concerns. Parents plan case against SII. AstraZeneca withdraws VaxAstraZeneca due to mutant variant strains.
What is new Covid variant FLiRT, is it dangerous, and what are the symptoms?
The FLiRT variant, a group of new Covid-19 variants belonging to Omicron's JN.1 lineage, is rapidly spreading in the US. Variants KP.2 and KP 1.1, considered more infectious than previous Omicron variants, are causing concern. Experts warn of a potential new wave of infections in the summer. Symptoms of FLiRT remain similar to other variants. Vaccination and preventive measures are advised.
A new form of mpox that may spread more easily found in Congo's biggest outbreak
Since January, Congo has reported more than 4,500 suspected mpox cases and nearly 300 deaths, numbers that have roughly tripled from the same period last year, according to the World Health Organization. Congo recently declared the outbreak across the country a health emergency.
Whooping cough spreading in China, 13 deaths in 2 months. Symptoms and if a vaccine is there
China experienced a significant surge in whooping cough cases in the first two months of 2024, with 32,380 cases reported compared to 1,421 in the same period in 2023. The disease, caused by Bordetella pertussis, can lead to severe complications.
Global private equity firms eye $1 billion bid for Bharat Serums and vaccines
Five global private equity firms, including Warburg Pincus, Permira, EQT, Bain, and TPG, are interested in bidding for Bharat Serums and Vaccines (BSV), which is seeking over $1 billion. The firms will sign expressions of interest soon and start due diligence on the Mumbai-based biopharmaceutical company. Advent International, the current owner, acquired BSV in 2019 and now wants to sell it. Some contenders may partner with pharmaceutical companies for the bid. Advent has engaged Jefferies and JP Morgan for the sale process.
IIT Guwahati completes technology transfer to BioMed for first recombinant vaccine for Swine Fever Virus
Indian Institute of Technology Guwahati transferred a pioneering vaccine technology to BioMed Pvt. Ltd. for a recombinant vector vaccine combating classical swine fever in pigs and wild boars, with research findings published in prestigious journals.
Drea de Matteo talks about OnlyFans, COVID-19 vaccine and how these change her life
Drea de Matteo has talked about tough times in her life. The actress, subsequently, joined subscription-based platform.
Takeda, Biological E enter manufacturing pact to produce 50 million doses of Dengue vaccine
Japanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase its manufacturing capacity to up to 50 million doses a year, supporting Takeda's goal to produce 100 million doses annually by 2030. The collaboration leverages Takeda's existing facility in Germany and its partnership with IDT Biologika GmbH.
WHO sees 'incredibly low' COVID, flu vaccination rates as cases surge
In the United States, several European countries, and other parts of the world, there have been reports of rising hospitalizations linked to respiratory infections in recent weeks. Death rates have also ticked up among older adults in some regions, but far below the COVID pandemic peak.
Spain considers nationwide hospital mask rule, as flu, COVID hit Europe
The European Centre for Disease Prevention and Control recommended that people on the continent stay home if they feel sick, and consider wearing masks in crowds or healthcare settings, with flu spreading as it typically does this time of year but hitting some countries harder than others.
Load More
